CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

Stock Information for Salarius Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Salarius Pharmaceuticals Inc.

CorMedix Therapeutics Announces Share Repurchase Program
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
Lost Money on CorMedix Inc. (CRMD)? Contact Levi & Korsinsky About Fraud Investigation
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
CorMedix Therapeutics Announces Leadership and Board Updates
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Strong Earnings and Biotech Resilience Define the Midweek Momentum

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.